Tags

Type your tag names separated by a space and hit enter

Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement.
Am J Respir Crit Care Med 2000; 161(4 Pt 2):S221-47AJ

Pub Type(s)

Guideline
Journal Article
Practice Guideline
Review

Language

eng

PubMed ID

10764341

Citation

"Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection. This Official Statement of the American Thoracic Society Was Adopted By the ATS Board of Directors, July 1999. This Is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This Statement Was Endorsed By the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the Sections of This Statement." American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 4 Pt 2, 2000, pp. S221-47.
Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med. 2000;161(4 Pt 2):S221-47.
(2000). Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. American Journal of Respiratory and Critical Care Medicine, 161(4 Pt 2), pp. S221-47.
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection. This Official Statement of the American Thoracic Society Was Adopted By the ATS Board of Directors, July 1999. This Is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This Statement Was Endorsed By the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the Sections of This Statement. Am J Respir Crit Care Med. 2000;161(4 Pt 2):S221-47. PubMed PMID: 10764341.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. PY - 2000/4/14/pubmed PY - 2000/6/3/medline PY - 2000/4/14/entrez SP - S221 EP - 47 JF - American journal of respiratory and critical care medicine JO - Am. J. Respir. Crit. Care Med. VL - 161 IS - 4 Pt 2 SN - 1073-449X UR - https://www.unboundmedicine.com/medline/citation/10764341/full_citation L2 - http://www.atsjournals.org/doi/full/10.1164/ajrccm.161.supplement_3.ats600?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -